Compare ALEMBIC PHARMA with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ASTRAZENECA PHARMA ALEMBIC PHARMA/
ASTRAZENECA PHARMA
 
P/E (TTM) x 16.6 82.7 20.1% View Chart
P/BV x 3.8 23.3 16.4% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 ALEMBIC PHARMA   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
ASTRAZENECA PHARMA
Mar-18
ALEMBIC PHARMA/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs6641,278 52.0%   
Low Rs412883 46.7%   
Sales per share (Unadj.) Rs208.7228.4 91.4%  
Earnings per share (Unadj.) Rs31.010.4 299.1%  
Cash flow per share (Unadj.) Rs37.116.3 228.2%  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.298.8 146.0%  
Shares outstanding (eoy) m188.5225.00 754.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.64.7 54.5%   
Avg P/E ratio x17.4104.2 16.7%  
P/CF ratio (eoy) x14.566.4 21.8%  
Price / Book Value ratio x3.710.9 34.1%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,46127,008 375.7%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m7,4671,535 486.3%   
Avg. sales/employee Rs ThNM4,210.9-  
Avg. wages/employee Rs ThNM1,132.2-  
Avg. net profit/employee Rs ThNM191.1-  
INCOME DATA
Net Sales Rs m39,3475,710 689.1%  
Other income Rs m94123 76.6%   
Total revenues Rs m39,4415,833 676.2%   
Gross profit Rs m8,736463 1,887.2%  
Depreciation Rs m1,152147 781.8%   
Interest Rs m1840-   
Profit before tax Rs m7,493438 1,710.8%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568179 876.2%   
Profit after tax Rs m5,844259 2,255.4%  
Gross profit margin %22.28.1 273.9%  
Effective tax rate %20.940.8 51.2%   
Net profit margin %14.94.5 327.3%  
BALANCE SHEET DATA
Current assets Rs m19,5773,209 610.0%   
Current liabilities Rs m14,8962,070 719.8%   
Net working cap to sales %11.920.0 59.6%  
Current ratio x1.31.6 84.8%  
Inventory Days Days9072 124.1%  
Debtors Days Days4535 129.9%  
Net fixed assets Rs m27,097790 3,428.7%   
Share capital Rs m37750 754.0%   
"Free" reserves Rs m26,8112,419 1,108.2%   
Net worth Rs m27,1882,469 1,101.0%   
Long term debt Rs m4,9930-   
Total assets Rs m47,7784,605 1,037.4%  
Interest coverage x41.7NM-  
Debt to equity ratio x0.20-  
Sales to assets ratio x0.81.2 66.4%   
Return on assets %12.65.6 224.3%  
Return on equity %21.510.5 204.8%  
Return on capital %23.617.7 133.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,453300 6,494.0%   
Fx outflow Rs m6,0652,015 301.0%   
Net fx Rs m13,388-1,715 -780.5%   
CASH FLOW
From Operations Rs m8,12088 9,237.3%  
From Investments Rs m-7,556-94 8,072.6%  
From Financial Activity Rs m590NA-  
Net Cashflow Rs m1,153-6 -20,233.3%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 2.9 0.3 966.7%  
FIIs % 9.1 15.7 58.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 9.1 152.7%  
Shareholders   49,328 12,856 383.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   AJANTA PHARMA  GLENMARK PHARMA  AUROBINDO PHARMA  STRIDES PHARMA SCIENCE  FDC LTD.  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views on News

ALEMBIC PHARMA Surges by 5%; BSE HEALTHCARE Index Up 0.9% (Market Updates)

Oct 17, 2019 | Updated on Oct 17, 2019

ALEMBIC PHARMA share price has surged by 5% and its current market price is Rs 550. The BSE HEALTHCARE is up by 0.9%. The top gainers in the BSE HEALTHCARE Index are ALEMBIC PHARMA (up 5.2%) and PIRAMAL ENTERPRISES (up 7.0%). The top losers are SYNGENE INTERNATIONAL (down 0.1%) and SHILPA MEDICARE (down 0.3%).

ASTRAZENECA PHARMA Surges by 6%; BSE HEALTHCARE Index Up 0.1% (Market Updates)

Oct 17, 2019 | Updated on Oct 17, 2019

ASTRAZENECA PHARMA share price has surged by 6% and its current market price is Rs 2,331. The BSE HEALTHCARE is up by 0.1%. The top gainers in the BSE HEALTHCARE Index is ASTRAZENECA PHARMA (up 5.6%). The top losers are THYROCARE TECHNOLOGIES (down 0.1%) and LAURUS LABS LTD (down 0.2%).

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Oct 17, 2019 03:37 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS